INTERFERON-INDUCED SUDDEN HEARING-LOSS

被引:0
作者
KANDA, Y
SHIGENO, K
MATSUO, H
YANO, M
YAMADA, N
KUMAGAMI, H
机构
[1] NAGASAKI CHUO NATL HOSP,DEPT OTOLARYNGOL,NAGASAKI,JAPAN
[2] NAGASAKI CHUO NATL HOSP,INST CLIN RES,NAGASAKI,JAPAN
[3] JAPANESE RED CROSS,NAGASAKI ATOM BOMB HOSP,DEPT NEUROL,NAGASAKI,JAPAN
[4] YAMADA OTOLARYNGOL CLIN,NAGASAKI,JAPAN
来源
AUDIOLOGY | 1995年 / 34卷 / 02期
关键词
INTERFERON; SUDDEN HEARING LOSS; AUTOIMMUNITY; OTOTOXICITY;
D O I
暂无
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
With the increasing long-term use of interferon (IFN), several new adverse effects have been recognized. Very little attention, however, has been paid to auditory acuity. We encountered 3 cases of sudden hearing loss associated with IFN, We then conducted a prospective study to assess the auditory function of 73 patients receiving IFN. Auditory disability (tinnitus and/or hearing loss) occurred in 32 patients (43.8%) during IFN therapy, among which audiometry documented sensorineural hearing loss in 27 cases (36.9%); 17 (48.6%) of the 35 patients receiving IFN-beta had auditory disability, including hearing loss in 13 cases (37.1%), and 15 (39.5%) of 38 patients receiving IFN-alpha suffered from auditory disability, There was not much difference between the influences of IFN-alpha and -beta. Auditory disability frequently developed in the later stages of treatment, and most patients recovered 7-14 days after the discontinuation of IFN. The results demonstrate that sudden hearing loss can occur as a side effect of treatment with IFN, This may reveal the association between autoimmunity and sudden hearing loss.
引用
收藏
页码:98 / 102
页数:5
相关论文
共 12 条
  • [1] INHIBITION OF CELL MOTILITY BY INTERFERON
    BROUTYBOYE, D
    ZETTER, BR
    [J]. SCIENCE, 1980, 208 (4443) : 516 - 518
  • [2] INTERFERON ENHANCES THE EXCITABILITY OF CULTURED NEURONS
    CALVET, MC
    GRESSER, I
    [J]. NATURE, 1979, 278 (5704) : 558 - 560
  • [3] COLE RR, 1988, AM J OTOL, V9, P211
  • [4] CONLON KC, 1990, CANCER, V65, P2237, DOI 10.1002/1097-0142(19900515)65:10<2237::AID-CNCR2820651013>3.0.CO
  • [5] 2-5
  • [6] INTERFERON-ASSOCIATED RETINOPATHY
    GUYER, DR
    TIEDEMAN, J
    YANNUZZI, LA
    SLAKTER, JS
    PARKE, D
    KELLEY, J
    TANG, RA
    MARMOR, M
    ABRAMS, G
    MILLER, JW
    GRAGOUDAS, ES
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1993, 111 (03) : 350 - 356
  • [7] SUDDEN HEARING-LOSS ASSOCIATED WITH INTERFERON
    KANDA, Y
    SHIGENO, K
    KINOSHITA, N
    NAKAO, K
    YANO, M
    MATSUO, H
    [J]. LANCET, 1994, 343 (8906) : 1134 - 1135
  • [8] MATSUDA J, 1992, JAP J CLIN MED, V50, P61
  • [9] CLINICAL TOXICITY OF INTERFERONS IN CANCER-PATIENTS - A REVIEW
    QUESADA, JR
    TALPAZ, M
    RIOS, A
    KURZROCK, R
    GUTTERMAN, JU
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (02) : 234 - 243
  • [10] SIDE-EFFECTS OF ALPHA INTERFERON
    RENAULT, PF
    HOOFNAGLE, JH
    [J]. SEMINARS IN LIVER DISEASE, 1989, 9 (04) : 273 - 277